Cellzome Study Suggests Epigenetic Inhibitors' Efficacy Depends on Protein-Complex Interactions

The research suggests that HDAC inhibitors may be more selective than previously thought, a finding that could help scientists more fully understand the biological pathways associated with the proteins and better identify potential epigenetic drug targets, said one of the researchers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.